Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 2, 2010


Joel McComb is leaving his post as senior vice president and general manager of Illumina's Life Sciences business to become chief operating officer at Synthetic Genomics. McComb departed Illumina and took on the new position at SGI on March 1.

Before his time at Illumina, McComb was at General Electric, where he was president of Healthcare Life Sciences-Discovery Systems, and he served as president of GE Healthcare, Interventional Medicine. He also previously served as president and CEO of Innovadyne Technologies, a liquid-handling technology firm.

McComb's departure agreement from Illumina entitles him to a severance payment of nearly $260,000.

Ulf Jönsson has joined PharmaDiagnostics as non-executive director, the firm said this week.

Jönsson previously served as CEO of Cellectricon. He also was a co-founder and CEO of Biacore, now part of GE Healthcare.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.